Scenarios that move BBIO
BridgeBio Pharma, Inc. - Common Stock
Scenarios that move BBIO: 3 analyses, 0 positive, 3 negative.
- · Ascendis Pharma receives positive CHMP opinion for TransCon CNP — ▼ · impact -35 · confidence low · horizon quarters
- · Ionis reports positive late-stage results for two partnered drugs — ▼ · impact -55 · confidence low · horizon weeks
- · Ascendis announces planned $400 million share repurchase program — ▼ · impact -12 · confidence low · horizon quarters